世界のキメラ融合タンパク質市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chimeric Fusion Protein Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1280
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、キメラ融合タンパク質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エタネルセプト、ベラタセプト、アバタセプト、アレファセプト、その他）、用途別市場規模（自己免疫、腫瘍、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・キメラ融合タンパク質の市場動向
・企業の競争状況、市場シェア
・キメラ融合タンパク質の種類別市場規模（エタネルセプト、ベラタセプト、アバタセプト、アレファセプト、その他）
・キメラ融合タンパク質の用途別市場規模（自己免疫、腫瘍、その他）
・キメラ融合タンパク質の北米市場規模2016-2027（アメリカ、カナダ）
・キメラ融合タンパク質のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・キメラ融合タンパク質のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・キメラ融合タンパク質の中南米市場規模2016-2027（メキシコ、ブラジル）
・キメラ融合タンパク質の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Astellas Pharma、Regeneron、Amgen、Ligand Pharmaceuticals、Bristol-Myers Squibb、Viventia、Genzyme）
・結論

Chimeric fusion proteins, produced by genetic engineering, are currently made up of effector peptides, for example, a ligand-binding portion of a cytokine or growth factor, extracellular domains of lymphocyte antigens, or a toxin linked to a suitable fusion partner.

Market Analysis and Insights: Global Chimeric Fusion Protein Market
The global Chimeric Fusion Protein market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chimeric Fusion Protein market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chimeric Fusion Protein market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chimeric Fusion Protein market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chimeric Fusion Protein market.

Global Chimeric Fusion Protein Scope and Market Size
Chimeric Fusion Protein market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chimeric Fusion Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Etanercept
Belatacept
Abatacept
Alefacept
Others

Segment by Application
Autoimmune
Tumor
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma
Regeneron
Amgen
Ligand Pharmaceuticals
Bristol-Myers Squibb

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Fusion Protein Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Etanercept
1.2.3 Belatacept
1.2.4 Abatacept
1.2.5 Alefacept
1.2.6 Others
1.3 Market by Application
1.3.1 Global Chimeric Fusion Protein Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chimeric Fusion Protein Market Perspective (2016-2027)
2.2 Chimeric Fusion Protein Growth Trends by Regions
2.2.1 Chimeric Fusion Protein Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chimeric Fusion Protein Historic Market Share by Regions (2016-2021)
2.2.3 Chimeric Fusion Protein Forecasted Market Size by Regions (2022-2027)
2.3 Chimeric Fusion Protein Industry Dynamic
2.3.1 Chimeric Fusion Protein Market Trends
2.3.2 Chimeric Fusion Protein Market Drivers
2.3.3 Chimeric Fusion Protein Market Challenges
2.3.4 Chimeric Fusion Protein Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chimeric Fusion Protein Players by Revenue
3.1.1 Global Top Chimeric Fusion Protein Players by Revenue (2016-2021)
3.1.2 Global Chimeric Fusion Protein Revenue Market Share by Players (2016-2021)
3.2 Global Chimeric Fusion Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chimeric Fusion Protein Revenue
3.4 Global Chimeric Fusion Protein Market Concentration Ratio
3.4.1 Global Chimeric Fusion Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Fusion Protein Revenue in 2020
3.5 Chimeric Fusion Protein Key Players Head office and Area Served
3.6 Key Players Chimeric Fusion Protein Product Solution and Service
3.7 Date of Enter into Chimeric Fusion Protein Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chimeric Fusion Protein Breakdown Data by Type
4.1 Global Chimeric Fusion Protein Historic Market Size by Type (2016-2021)
4.2 Global Chimeric Fusion Protein Forecasted Market Size by Type (2022-2027)

5 Chimeric Fusion Protein Breakdown Data by Application
5.1 Global Chimeric Fusion Protein Historic Market Size by Application (2016-2021)
5.2 Global Chimeric Fusion Protein Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chimeric Fusion Protein Market Size (2016-2027)
6.2 North America Chimeric Fusion Protein Market Size by Type
6.2.1 North America Chimeric Fusion Protein Market Size by Type (2016-2021)
6.2.2 North America Chimeric Fusion Protein Market Size by Type (2022-2027)
6.2.3 North America Chimeric Fusion Protein Market Size by Type (2016-2027)
6.3 North America Chimeric Fusion Protein Market Size by Application
6.3.1 North America Chimeric Fusion Protein Market Size by Application (2016-2021)
6.3.2 North America Chimeric Fusion Protein Market Size by Application (2022-2027)
6.3.3 North America Chimeric Fusion Protein Market Size by Application (2016-2027)
6.4 North America Chimeric Fusion Protein Market Size by Country
6.4.1 North America Chimeric Fusion Protein Market Size by Country (2016-2021)
6.4.2 North America Chimeric Fusion Protein Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chimeric Fusion Protein Market Size (2016-2027)
7.2 Europe Chimeric Fusion Protein Market Size by Type
7.2.1 Europe Chimeric Fusion Protein Market Size by Type (2016-2021)
7.2.2 Europe Chimeric Fusion Protein Market Size by Type (2022-2027)
7.2.3 Europe Chimeric Fusion Protein Market Size by Type (2016-2027)
7.3 Europe Chimeric Fusion Protein Market Size by Application
7.3.1 Europe Chimeric Fusion Protein Market Size by Application (2016-2021)
7.3.2 Europe Chimeric Fusion Protein Market Size by Application (2022-2027)
7.3.3 Europe Chimeric Fusion Protein Market Size by Application (2016-2027)
7.4 Europe Chimeric Fusion Protein Market Size by Country
7.4.1 Europe Chimeric Fusion Protein Market Size by Country (2016-2021)
7.4.2 Europe Chimeric Fusion Protein Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chimeric Fusion Protein Market Size (2016-2027)
8.2 Asia-Pacific Chimeric Fusion Protein Market Size by Type
8.2.1 Asia-Pacific Chimeric Fusion Protein Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chimeric Fusion Protein Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chimeric Fusion Protein Market Size by Type (2016-2027)
8.3 Asia-Pacific Chimeric Fusion Protein Market Size by Application
8.3.1 Asia-Pacific Chimeric Fusion Protein Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chimeric Fusion Protein Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chimeric Fusion Protein Market Size by Application (2016-2027)
8.4 Asia-Pacific Chimeric Fusion Protein Market Size by Region
8.4.1 Asia-Pacific Chimeric Fusion Protein Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chimeric Fusion Protein Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chimeric Fusion Protein Market Size (2016-2027)
9.2 Latin America Chimeric Fusion Protein Market Size by Type
9.2.1 Latin America Chimeric Fusion Protein Market Size by Type (2016-2021)
9.2.2 Latin America Chimeric Fusion Protein Market Size by Type (2022-2027)
9.2.3 Latin America Chimeric Fusion Protein Market Size by Type (2016-2027)
9.3 Latin America Chimeric Fusion Protein Market Size by Application
9.3.1 Latin America Chimeric Fusion Protein Market Size by Application (2016-2021)
9.3.2 Latin America Chimeric Fusion Protein Market Size by Application (2022-2027)
9.3.3 Latin America Chimeric Fusion Protein Market Size by Application (2016-2027)
9.4 Latin America Chimeric Fusion Protein Market Size by Country
9.4.1 Latin America Chimeric Fusion Protein Market Size by Country (2016-2021)
9.4.2 Latin America Chimeric Fusion Protein Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chimeric Fusion Protein Market Size (2016-2027)
10.2 Middle East & Africa Chimeric Fusion Protein Market Size by Type
10.2.1 Middle East & Africa Chimeric Fusion Protein Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chimeric Fusion Protein Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chimeric Fusion Protein Market Size by Type (2016-2027)
10.3 Middle East & Africa Chimeric Fusion Protein Market Size by Application
10.3.1 Middle East & Africa Chimeric Fusion Protein Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chimeric Fusion Protein Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chimeric Fusion Protein Market Size by Application (2016-2027)
10.4 Middle East & Africa Chimeric Fusion Protein Market Size by Country
10.4.1 Middle East & Africa Chimeric Fusion Protein Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chimeric Fusion Protein Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Chimeric Fusion Protein Introduction
11.1.4 Astellas Pharma Revenue in Chimeric Fusion Protein Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Regeneron
11.2.1 Regeneron Company Details
11.2.2 Regeneron Business Overview
11.2.3 Regeneron Chimeric Fusion Protein Introduction
11.2.4 Regeneron Revenue in Chimeric Fusion Protein Business (2016-2021)
11.2.5 Regeneron Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Chimeric Fusion Protein Introduction
11.3.4 Amgen Revenue in Chimeric Fusion Protein Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Ligand Pharmaceuticals
11.4.1 Ligand Pharmaceuticals Company Details
11.4.2 Ligand Pharmaceuticals Business Overview
11.4.3 Ligand Pharmaceuticals Chimeric Fusion Protein Introduction
11.4.4 Ligand Pharmaceuticals Revenue in Chimeric Fusion Protein Business (2016-2021)
11.4.5 Ligand Pharmaceuticals Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Chimeric Fusion Protein Introduction
11.5.4 Bristol-Myers Squibb Revenue in Chimeric Fusion Protein Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Viventia
11.6.1 Viventia Company Details
11.6.2 Viventia Business Overview
11.6.3 Viventia Chimeric Fusion Protein Introduction
11.6.4 Viventia Revenue in Chimeric Fusion Protein Business (2016-2021)
11.6.5 Viventia Recent Development
11.7 Genzyme
11.7.1 Genzyme Company Details
11.7.2 Genzyme Business Overview
11.7.3 Genzyme Chimeric Fusion Protein Introduction
11.7.4 Genzyme Revenue in Chimeric Fusion Protein Business (2016-2021)
11.7.5 Genzyme Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chimeric Fusion Protein Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Etanercept
Table 3. Key Players of Belatacept
Table 4. Key Players of Abatacept
Table 5. Key Players of Alefacept
Table 6. Key Players of Others
Table 7. Global Chimeric Fusion Protein Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chimeric Fusion Protein Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Chimeric Fusion Protein Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Chimeric Fusion Protein Market Share by Regions (2016-2021)
Table 11. Global Chimeric Fusion Protein Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Chimeric Fusion Protein Market Share by Regions (2022-2027)
Table 13. Chimeric Fusion Protein Market Trends
Table 14. Chimeric Fusion Protein Market Drivers
Table 15. Chimeric Fusion Protein Market Challenges
Table 16. Chimeric Fusion Protein Market Restraints
Table 17. Global Chimeric Fusion Protein Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Chimeric Fusion Protein Market Share by Players (2016-2021)
Table 19. Global Top Chimeric Fusion Protein Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Fusion Protein as of 2020)
Table 20. Ranking of Global Top Chimeric Fusion Protein Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Chimeric Fusion Protein Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chimeric Fusion Protein Product Solution and Service
Table 24. Date of Enter into Chimeric Fusion Protein Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Chimeric Fusion Protein Revenue Market Share by Type (2016-2021)
Table 28. Global Chimeric Fusion Protein Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Chimeric Fusion Protein Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Chimeric Fusion Protein Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Chimeric Fusion Protein Revenue Market Share by Application (2016-2021)
Table 32. Global Chimeric Fusion Protein Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Chimeric Fusion Protein Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Chimeric Fusion Protein Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Chimeric Fusion Protein Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Chimeric Fusion Protein Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Chimeric Fusion Protein Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Chimeric Fusion Protein Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Chimeric Fusion Protein Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Chimeric Fusion Protein Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Chimeric Fusion Protein Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Chimeric Fusion Protein Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Chimeric Fusion Protein Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chimeric Fusion Protein Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chimeric Fusion Protein Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Chimeric Fusion Protein Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Chimeric Fusion Protein Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Chimeric Fusion Protein Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Chimeric Fusion Protein Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Chimeric Fusion Protein Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Chimeric Fusion Protein Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Chimeric Fusion Protein Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Chimeric Fusion Protein Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chimeric Fusion Protein Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chimeric Fusion Protein Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chimeric Fusion Protein Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Chimeric Fusion Protein Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Chimeric Fusion Protein Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Chimeric Fusion Protein Market Size by Country (2022-2027) & (US$ Million)
Table 64. Astellas Pharma Company Details
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma Chimeric Fusion Protein Product
Table 67. Astellas Pharma Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 68. Astellas Pharma Recent Development
Table 69. Regeneron Company Details
Table 70. Regeneron Business Overview
Table 71. Regeneron Chimeric Fusion Protein Product
Table 72. Regeneron Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 73. Regeneron Recent Development
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Chimeric Fusion Protein Product
Table 77. Amgen Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 78. Amgen Recent Development
Table 79. Ligand Pharmaceuticals Company Details
Table 80. Ligand Pharmaceuticals Business Overview
Table 81. Ligand Pharmaceuticals Chimeric Fusion Protein Product
Table 82. Ligand Pharmaceuticals Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 83. Ligand Pharmaceuticals Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Chimeric Fusion Protein Product
Table 87. Bristol-Myers Squibb Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Viventia Company Details
Table 90. Viventia Business Overview
Table 91. Viventia Chimeric Fusion Protein Product
Table 92. Viventia Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 93. Viventia Recent Development
Table 94. Genzyme Company Details
Table 95. Genzyme Business Overview
Table 96. Genzyme Chimeric Fusion Protein Product
Table 97. Genzyme Revenue in Chimeric Fusion Protein Business (2016-2021) & (US$ Million)
Table 98. Genzyme Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Fusion Protein Market Share by Type: 2020 VS 2027
Figure 2. Etanercept Features
Figure 3. Belatacept Features
Figure 4. Abatacept Features
Figure 5. Alefacept Features
Figure 6. Others Features
Figure 7. Global Chimeric Fusion Protein Market Share by Application: 2020 VS 2027
Figure 8. Autoimmune Case Studies
Figure 9. Tumor Case Studies
Figure 10. Others Case Studies
Figure 11. Chimeric Fusion Protein Report Years Considered
Figure 12. Global Chimeric Fusion Protein Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Chimeric Fusion Protein Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Chimeric Fusion Protein Market Share by Regions: 2020 VS 2027
Figure 15. Global Chimeric Fusion Protein Market Share by Regions (2022-2027)
Figure 16. Global Chimeric Fusion Protein Market Share by Players in 2020
Figure 17. Global Top Chimeric Fusion Protein Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Fusion Protein as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Chimeric Fusion Protein Revenue in 2020
Figure 19. Global Chimeric Fusion Protein Revenue Market Share by Type (2016-2021)
Figure 20. Global Chimeric Fusion Protein Revenue Market Share by Type (2022-2027)
Figure 21. North America Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Chimeric Fusion Protein Market Share by Type (2016-2027)
Figure 23. North America Chimeric Fusion Protein Market Share by Application (2016-2027)
Figure 24. North America Chimeric Fusion Protein Market Share by Country (2016-2027)
Figure 25. United States Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Chimeric Fusion Protein Market Share by Type (2016-2027)
Figure 29. Europe Chimeric Fusion Protein Market Share by Application (2016-2027)
Figure 30. Europe Chimeric Fusion Protein Market Share by Country (2016-2027)
Figure 31. Germany Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Chimeric Fusion Protein Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Chimeric Fusion Protein Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Chimeric Fusion Protein Market Share by Region (2016-2027)
Figure 41. China Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Chimeric Fusion Protein Market Share by Type (2016-2027)
Figure 49. Latin America Chimeric Fusion Protein Market Share by Application (2016-2027)
Figure 50. Latin America Chimeric Fusion Protein Market Share by Country (2016-2027)
Figure 51. Mexico Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Chimeric Fusion Protein Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Chimeric Fusion Protein Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Chimeric Fusion Protein Market Share by Country (2016-2027)
Figure 57. Turkey Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Chimeric Fusion Protein Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Astellas Pharma Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 61. Regeneron Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 63. Ligand Pharmaceuticals Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 65. Viventia Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 66. Genzyme Revenue Growth Rate in Chimeric Fusion Protein Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のキメラ融合タンパク質市場規模・現状・予測（2021年-2027年）

Global Chimeric Fusion Protein Market Size, Status and Forecast 2021-2027
QYR2104Z1280 2021年4月 94Pages
QYResearch社発行の本調査資料では、キメラ融合タンパク質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エタネルセプト、ベラタセプト、アバタセプト、アレファセプト、その他）、用途別市場規模（自己免疫、腫瘍、その他）、主要地域別市場規模（...

世界の融合タンパク質市場規模・現状・予測（2021年-2027年）

Global Fusion Protein Market Size, Status and Forecast 2021-2027
QYR2104Z2473 2021年4月 98Pages
QYResearch社発行の本調査資料では、融合タンパク質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン（Ig）融合タンパク質、副甲状腺ホルモン（PTH）融合タンパク質、サイトカイン組換え融合タンパク質、その他）、用途別市場規模...

世界の融合タンパク質セラピー法市場規模・現状・予測（2021年-2027年）

Global Fusion Protein Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z2474 2021年4月 129Pages
QYResearch社発行の本調査資料では、融合タンパク質セラピー法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン（Ig）融合タンパク質、副甲状腺ホルモン（PTH）融合タンパク質、サイトカイン組換え融合タンパク質、その他）、用途...

世界の骨形成タンパク質（BMP）2市場規模・現状・予測（2021年-2027年）

Global Bone Morphogenetic Protein (BMP) 2 Market Size, Status and Forecast 2021-2027
QYR2104Z0949 2021年4月 93Pages
QYResearch社発行の本調査資料では、骨形成タンパク質（BMP）2のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スポンジ、ジェル）、用途別市場規模（脊椎固定術、外傷手術、口腔顎顔面手術、再建手術）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の腰椎固定術市場規模・現状・予測（2021年-2027年）

Global Lumbar Spine Fusion Market Size, Status and Forecast 2021-2027
QYR2104Z3487 2021年4月 98Pages
QYResearch社発行の本調査資料では、腰椎固定術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来型、低侵襲的）、用途別市場規模（病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の脊椎非融合技術市場規模・現状・予測（2021年-2027年）

Global Spinal Non Fusion Technologies Market Size, Status and Forecast 2021-2027
QYR2104Z5405 2021年4月 91Pages
QYResearch社発行の本調査資料では、脊椎非融合技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（動的安定化装置、椎間板核置換製品、線維輪修復装置、核椎間板プロテーゼ、椎間板関節形成術装置、核関節形成術装置）、用途別市場規模（椎間板変性...

世界の脊椎固定術市場規模・現状・予測（2021年-2027年）

Global Spinal Fusion Market Size, Status and Forecast 2021-2027
QYR2104Z5398 2021年4月 96Pages
QYResearch社発行の本調査資料では、脊椎固定術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経椎間孔腰椎椎体間固定術（TLIF）、前方腰椎椎体間固定術（ALIF）、後方腰椎椎体間固定術（PLIF）、後方腰椎固定術（PLF）、極端外側椎...

世界のタンパク質包装市場規模・現状・予測（2021年-2027年）

Global Protein Packaging Market Size, Status and Forecast 2021-2027
QYR2104Z4845 2021年4月 90Pages
QYResearch社発行の本調査資料では、タンパク質包装のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フレキシブル包装、リジッド包装）、用途別市場規模（栄養素、栄養補助食品）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の微生物タンパク質（ガプリン）市場規模・現状・予測（2021年-2027年）

Global Microbiological Protein (Gaprin) Market Size, Status and Forecast 2021-2027
QYR2104Z3754 2021年4月 99Pages
QYResearch社発行の本調査資料では、微生物タンパク質（ガプリン）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（食品用、飼料用）、用途別市場規模（食品・飲料、動物飼料、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の外側腰椎椎体間固定術市場規模・現状・予測（2021年-2027年）

Global Lateral Lumbar Interbody Fusion Market Size, Status and Forecast 2021-2027
QYR2104Z3382 2021年4月 134Pages
QYResearch社発行の本調査資料では、外側腰椎椎体間固定術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（器具、インプラント、サポートデバイス）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界のキメラ融合タンパク質市場規模・現状・予測（2021年-2027年） Chimeric fusion proteins, produced by genetic engineering, are currently made up of effector peptides, for example, a ligand-binding portion of a cytokine or growth factor, extracellular domains of lymphocyte antigens, or a toxin linked to a suitable fusion partner. Market Analysis and Insights: Glo…
世界の融合タンパク質市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fusion Protein Market The global Fusion Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
世界の融合タンパク質セラピー法市場規模・現状・予測（2021年-2027年） Fusion proteins or chimeric (kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins. Market Analysis and Insights: Global Fusion Protein Therapy Market The global Fusion Protein…
世界の骨形成タンパク質（BMP）2市場規模・現状・予測（2021年-2027年） Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenanc…
世界の腰椎固定術市場規模・現状・予測（2021年-2027年） Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Over the recent years…